Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 14/20 | 0.56 |
| ▸ | DRD2 | P14416 | 10/20 | 0.56 |
| ▸ | DRD5 | P21918 | 10/20 | 0.56 |
| ▸ | DRD3 | P35462 | 9/20 | 0.56 |
| ▸ | DRD4 | P21917 | 7/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11027184 | 0.98 | DRD1 (0.55) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL1282891 | 0.89 | DRD1 (0.53) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL6211902 | 0.87 | CHRM2 (0.49) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL5501377 | 0.84 | DRD2 (0.56) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL15152114 | 0.81 | APP (0.44) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL28141288 | 0.78 | DRD2 (0.48) | DRD1DRD2DRD5DRD3DRD4 | |
| SCHEMBL3999191 | 0.78 | MAPT (0.44) | DRD1DRD2ESR2NOTUMHTR2A | |
| SCHEMBL2625792 | 0.78 | ALDH1A1 (0.50) | DRD2DRD4NOTUM | |
| SCHEMBL2625797 | 0.76 | CHRM2 (0.45) | DRD2DRD4NOTUMCHRM2 | |
| SCHEMBL21761195 | 0.76 | NOTUM (0.43) | DRD1DRD2DRD5DRD3NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3113753-B2 | AQUEOUS OXIDIZING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2026-03-18 | — | — | EP | disclosed |
| WO-2022087624-A1 | COMPOUNDS AS RAS INHIBITORS AND USES THEREOF | BIOARDIS LLC (US) | 2022-04-28 | — | — | WO | disclosed |
| EP-3113753-B1 | AQUEOUS OXIDIZING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2021-06-16 | — | — | EP | disclosed |
| EP-3113748-B1 | PROCESS FOR MANUFACTURING AN EMULSION | KAO GERMANY GMBH (DE) | 2021-05-12 | — | — | EP | disclosed |
| EP-3113847-B1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2019-11-20 | — | — | EP | disclosed |
| US-10385026-B2 | Phthalazinones and isoquinolinones as rock inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-08-20 | — | — | US | disclosed |
| EP-2346483-B1 | Composition and process for treating hair | KAO GERMANY GMBH (DE) | 2019-04-03 | — | — | EP | disclosed |
| US-10238588-B2 | Aqueous oxidizing composition for hair | KAO GERMANY GMBH (DE) | 2019-03-26 | — | — | US | disclosed |
| EP-3113848-B1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2018-10-31 | — | — | EP | disclosed |
| EP-2717848-B1 | HAIR COLOURING COMPOSITION | KAO GERMANY GMBH (DE) | 2018-07-11 | — | — | EP | disclosed |
| US-20060174424-A1 | Composition for dyeing human hair | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2006-08-10 | — | — | US | disclosed |
| EP-1676605-A1 | Product for hair dyeing | KPSS-Kao Professional Salon Services GmbH (DE) | 2006-07-05 | — | — | EP | disclosed |
| EP-1645264-A1 | Product for hair dyeing in a two chamber aerosol can | KPSS-Kao Professional Salon Services GmbH (DE) | 2006-04-12 | — | — | EP | disclosed |
| EP-1632218-A1 | Composition for dyeing keratin fibres | KPSS-Kao Professional Salon Services GmbH (DE) | 2006-03-08 | — | — | EP | disclosed |
| EP-1627666-A1 | Composition for dyeing keratin fibres | KPSS-Kao Professional Salon Services GmbH (DE) | 2006-02-22 | — | — | EP | disclosed |
| US-20050257334-A1 | Composition for dyeing keratin fibers | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2005-11-24 | — | — | US | disclosed |
| US-20050257331-A1 | Composition for dyeing of keratin fibres | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2005-11-24 | — | — | US | disclosed |
| EP-1598052-A1 | Composition for bleaching and dyeing keratin fibres | KPSS-Kao Professional Salon Services GmbH (DE) | 2005-11-23 | — | — | EP | disclosed |
| EP-1559403-A1 | Composition for dyeing human hair | KPSS-Kao Professional Salon Services GmbH (DE) | 2005-08-03 | — | — | EP | disclosed |
| US-5256799-A | Preparation of 6-hydroxyindolines and their use for preparation of novel laser dyes | THE UNITED STATES OF AMERICAS AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1993-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060174424-A1 | Composition for dyeing human hair | CYB5R3, MT-ND5, COX5A | DRD1 478/4885DRD2 801/4885DRD5 244/4885 |
| US-20050257331-A1 | Composition for dyeing of keratin fibres | KRT18, KCNH3, MT-CO3 | DRD1 1416/4885DRD2 1549/4885DRD5 340/4885 |
| US-10385026-B2 | Phthalazinones and isoquinolinones as rock inhibitors | MYLK, MYLK2, ROCK1 | DRD1 4598/4885DRD2 4484/4885DRD5 4007/4885 |
| US-10238588-B2 | Aqueous oxidizing composition for hair | POLR1C, GPX4, COXFA4 | DRD1 817/4885DRD2 1080/4885DRD5 716/4885 |
| US-20050257334-A1 | Composition for dyeing keratin fibers | KRT18, H1-5, CYB5R3 | DRD1 1200/4885DRD2 1548/4885DRD5 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.